CCI
ALXN
Columbus Circle Investors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-188,836
| Closed | -$21M | – | 224 |
|
2018
Q1 | $21M | Sell |
188,836
-42,966
| -19% | -$4.79M | 0.43% | 93 |
|
2017
Q4 | $27.7M | Sell |
231,802
-51,546
| -18% | -$6.16M | 0.53% | 73 |
|
2017
Q3 | $39.8M | Buy |
283,348
+203,358
| +254% | +$28.5M | 0.68% | 49 |
|
2017
Q2 | $9.73M | Buy |
79,990
+4,194
| +6% | +$510K | 0.16% | 127 |
|
2017
Q1 | $9.19M | Buy |
75,796
+13,183
| +21% | +$1.6M | 0.13% | 154 |
|
2016
Q4 | $7.66M | Sell |
62,613
-46,402
| -43% | -$5.68M | 0.1% | 170 |
|
2016
Q3 | $13.4M | Sell |
109,015
-8,023
| -7% | -$983K | 0.14% | 129 |
|
2016
Q2 | $13.7M | Sell |
117,038
-485,571
| -81% | -$56.7M | 0.14% | 146 |
|
2016
Q1 | $83.9M | Sell |
602,609
-204,193
| -25% | -$28.4M | 0.75% | 43 |
|
2015
Q4 | $154M | Buy |
806,802
+252,128
| +45% | +$48.1M | 1.23% | 23 |
|
2015
Q3 | $86.7M | Buy |
554,674
+13,943
| +3% | +$2.18M | 0.71% | 44 |
|
2015
Q2 | $97.7M | Sell |
540,731
-152,879
| -22% | -$27.6M | 0.69% | 43 |
|
2015
Q1 | $120M | Buy |
693,610
+214,642
| +45% | +$37.2M | 0.82% | 36 |
|
2014
Q4 | $88.6M | Buy |
478,968
+310,627
| +185% | +$57.5M | 0.63% | 47 |
|
2014
Q3 | $27.9M | Buy |
168,341
+29,930
| +22% | +$4.96M | 0.2% | 118 |
|
2014
Q2 | $21.6M | Buy |
+138,411
| New | +$21.6M | 0.15% | 140 |
|
2014
Q1 | – | Sell |
-35,793
| Closed | -$4.76M | – | 341 |
|
2013
Q4 | $4.76M | Sell |
35,793
-235,428
| -87% | -$31.3M | 0.03% | 248 |
|
2013
Q3 | $31.5M | Sell |
271,221
-90,369
| -25% | -$10.5M | 0.22% | 121 |
|
2013
Q2 | $33.4M | Buy |
+361,590
| New | +$33.4M | 0.27% | 103 |
|